NOTE 16 - SHARE BASED AND OTHER COMPENSATION

For the three months ended March 31, 2020 and 2019, the Company's share-based compensation consisted of the following (dollars in thousands):



	Three Months Ended March 31,
	2020							2019
	Stock Options			Restricted Stock		Total		Stock Options		Restricted Stock		Total
Share based compensation expensed	$	(4	)	$	1,067	$	1,063	$	391	$	3,254	$	3,645
Unrecognized share-based compensation costs	$	53		$	617	$	670	$	294	$	5,057	$	5,351
Weighted average amortization period remaining (in years)	0.92			0.70				0.32		0.73

Restricted Stock

A summary of restricted stock grant activity pursuant to the 2012 Plan and the 2016 Plan for the three months ended March 31, 2020, is presented below:



	Number of Shares		Weighted Average Grant Date Price
Outstanding at January 1, 2020	1,402,175		$	1.26
Granted	4,431,817		$	0.22
Vested and issued	(4,575,402	)	$	2.39
Forfeited or canceled ⁽¹⁾	(632,083	)	$	2.94
Outstanding at March 31, 2020	626,507		$	1.26

⁽¹⁾ Forfeitures are accounted for as and when incurred.

Under the Plan contemplated by the RSA, each outstanding share of restricted stock that has been vested and issued will be canceled for no consideration. See Note 2 - Chapter 11 Filing, Liquidity and Going Concern for a description of the terms of the Chapter 11 Cases.

Stock Options

A summary of stock option activity pursuant to the 2016 Plan for the three months ended March 31, 2020 , is presented below:



	Number of Options		Weighted Average Exercise Price		Number of Options Vested/ Exercisable	Weighted Average Remaining Contractual Life (Years)
Outstanding at January 1, 2020	3,588,350		$	4.05	3,487,792	7.2
Forfeited or canceled ⁽¹⁾	(132,325	)	$	3.14
Outstanding at March 31, 2020	3,456,025		$	4.05	3,416,093	7.2

⁽¹⁾Forfeitures are accounted for as and when incurred.

The Company expects that the outstanding stock options will be cancelled for no consideration in the Chapter 11 Cases.